Mingxiao Yang, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acupuncture Therapy | 18 | 2023 | 480 | 4.550 |
Why?
|
Drugs, Chinese Herbal | 4 | 2023 | 151 | 1.710 |
Why?
|
Acupuncture Points | 7 | 2023 | 111 | 1.570 |
Why?
|
Moxibustion | 3 | 2017 | 8 | 1.180 |
Why?
|
Electroacupuncture | 5 | 2021 | 66 | 1.110 |
Why?
|
Peripheral Nervous System Diseases | 3 | 2024 | 708 | 0.930 |
Why?
|
Tai Ji | 2 | 2024 | 287 | 0.920 |
Why?
|
Plants, Medicinal | 1 | 2023 | 166 | 0.810 |
Why?
|
Low Back Pain | 3 | 2022 | 979 | 0.790 |
Why?
|
Dysmenorrhea | 3 | 2018 | 98 | 0.780 |
Why?
|
Medicine, Traditional | 1 | 2021 | 87 | 0.730 |
Why?
|
Plant Preparations | 1 | 2021 | 94 | 0.720 |
Why?
|
Placebo Effect | 1 | 2024 | 520 | 0.690 |
Why?
|
Postural Balance | 1 | 2024 | 617 | 0.690 |
Why?
|
Cellobiose | 1 | 2018 | 4 | 0.660 |
Why?
|
Hypoxanthine | 1 | 2018 | 28 | 0.650 |
Why?
|
Sleep Initiation and Maintenance Disorders | 3 | 2023 | 1079 | 0.620 |
Why?
|
Sucrose | 1 | 2018 | 156 | 0.610 |
Why?
|
Analgesics | 3 | 2021 | 1065 | 0.590 |
Why?
|
Migraine Disorders | 3 | 2020 | 1693 | 0.550 |
Why?
|
Oleic Acid | 1 | 2016 | 92 | 0.530 |
Why?
|
Constipation | 1 | 2021 | 561 | 0.530 |
Why?
|
Medicine, Chinese Traditional | 2 | 2022 | 73 | 0.520 |
Why?
|
Inositol | 1 | 2016 | 215 | 0.500 |
Why?
|
Massage | 1 | 2014 | 86 | 0.470 |
Why?
|
Pain Measurement | 9 | 2024 | 3527 | 0.470 |
Why?
|
Metabolomics | 3 | 2024 | 1628 | 0.390 |
Why?
|
Acupressure | 2 | 2021 | 16 | 0.370 |
Why?
|
Randomized Controlled Trials as Topic | 10 | 2023 | 10343 | 0.330 |
Why?
|
Neoplasms | 5 | 2024 | 22075 | 0.280 |
Why?
|
Pain | 3 | 2020 | 5066 | 0.270 |
Why?
|
Clinical Protocols | 4 | 2016 | 1440 | 0.270 |
Why?
|
China | 6 | 2020 | 2339 | 0.240 |
Why?
|
Research Design | 4 | 2019 | 6180 | 0.220 |
Why?
|
Panax | 1 | 2023 | 28 | 0.210 |
Why?
|
Blood Pressure | 1 | 2018 | 8525 | 0.210 |
Why?
|
Glucose | 1 | 2014 | 4350 | 0.210 |
Why?
|
Seeds | 1 | 2023 | 120 | 0.210 |
Why?
|
Medicine, East Asian Traditional | 1 | 2022 | 18 | 0.200 |
Why?
|
Administration, Topical | 1 | 2024 | 697 | 0.200 |
Why?
|
Tibet | 1 | 2021 | 10 | 0.200 |
Why?
|
Hypertension | 2 | 2018 | 8595 | 0.190 |
Why?
|
Catechol O-Methyltransferase | 1 | 2023 | 251 | 0.190 |
Why?
|
Electronics | 1 | 2022 | 315 | 0.190 |
Why?
|
Diclofenac | 1 | 2021 | 67 | 0.180 |
Why?
|
Antiemetics | 1 | 2022 | 187 | 0.180 |
Why?
|
Mass Spectrometry | 2 | 2018 | 2192 | 0.180 |
Why?
|
Muscle Strength | 1 | 2024 | 619 | 0.170 |
Why?
|
Humans | 42 | 2024 | 760613 | 0.170 |
Why?
|
Yoga | 1 | 2024 | 281 | 0.170 |
Why?
|
Treatment Outcome | 12 | 2024 | 64981 | 0.170 |
Why?
|
Defecation | 1 | 2021 | 190 | 0.170 |
Why?
|
Spondylosis | 1 | 2019 | 85 | 0.160 |
Why?
|
Complementary Therapies | 1 | 2023 | 486 | 0.160 |
Why?
|
Endocrine System | 1 | 2019 | 112 | 0.160 |
Why?
|
Neck Pain | 1 | 2019 | 186 | 0.150 |
Why?
|
Bandages | 1 | 2018 | 270 | 0.140 |
Why?
|
Nervous System | 1 | 2019 | 543 | 0.130 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2018 | 1544 | 0.120 |
Why?
|
Dyspepsia | 1 | 2016 | 118 | 0.120 |
Why?
|
Female | 20 | 2024 | 391246 | 0.120 |
Why?
|
Electric Impedance | 1 | 2018 | 755 | 0.110 |
Why?
|
Pain Perception | 1 | 2014 | 196 | 0.110 |
Why?
|
Migraine without Aura | 1 | 2013 | 82 | 0.110 |
Why?
|
Antineoplastic Agents | 3 | 2024 | 13627 | 0.100 |
Why?
|
Headache | 1 | 2020 | 1249 | 0.100 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2016 | 377 | 0.100 |
Why?
|
Double-Blind Method | 2 | 2024 | 12427 | 0.100 |
Why?
|
Middle Aged | 9 | 2024 | 220359 | 0.090 |
Why?
|
Breast Neoplasms | 3 | 2024 | 21029 | 0.090 |
Why?
|
Bibliometrics | 1 | 2014 | 351 | 0.090 |
Why?
|
Fertilization in Vitro | 1 | 2018 | 1292 | 0.090 |
Why?
|
Pain Threshold | 1 | 2014 | 603 | 0.090 |
Why?
|
Adult | 12 | 2024 | 220007 | 0.080 |
Why?
|
Metabolome | 1 | 2016 | 982 | 0.080 |
Why?
|
Genotype | 1 | 2023 | 12957 | 0.080 |
Why?
|
Dietary Supplements | 1 | 2021 | 3392 | 0.070 |
Why?
|
Brain | 1 | 2014 | 26951 | 0.070 |
Why?
|
Exercise | 1 | 2024 | 5787 | 0.070 |
Why?
|
Quality Improvement | 1 | 2023 | 3835 | 0.070 |
Why?
|
Disability Evaluation | 1 | 2014 | 1826 | 0.070 |
Why?
|
Exercise Therapy | 2 | 2024 | 919 | 0.070 |
Why?
|
Analgesics, Opioid | 1 | 2023 | 3763 | 0.070 |
Why?
|
Sleep | 1 | 2023 | 4750 | 0.070 |
Why?
|
Male | 10 | 2024 | 359718 | 0.070 |
Why?
|
Aged | 6 | 2024 | 169143 | 0.070 |
Why?
|
Young Adult | 6 | 2019 | 58748 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 15790 | 0.060 |
Why?
|
Arachidonic Acids | 1 | 2024 | 294 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3696 | 0.050 |
Why?
|
Hong Kong | 1 | 2022 | 162 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7475 | 0.050 |
Why?
|
Time Factors | 4 | 2018 | 40139 | 0.050 |
Why?
|
Hot Flashes | 1 | 2023 | 328 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11345 | 0.040 |
Why?
|
Hormones | 1 | 2024 | 867 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12289 | 0.040 |
Why?
|
Phytotherapy | 1 | 2022 | 295 | 0.040 |
Why?
|
Nausea | 1 | 2022 | 678 | 0.040 |
Why?
|
Vomiting | 1 | 2022 | 650 | 0.040 |
Why?
|
Steroids | 1 | 2024 | 928 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6465 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15286 | 0.040 |
Why?
|
Publication Bias | 1 | 2018 | 162 | 0.040 |
Why?
|
Amino Acids | 1 | 2024 | 1714 | 0.040 |
Why?
|
Humidity | 1 | 2018 | 205 | 0.030 |
Why?
|
Clomiphene | 1 | 2016 | 71 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2018 | 713 | 0.030 |
Why?
|
Pregnancy Rate | 1 | 2018 | 649 | 0.030 |
Why?
|
Calcium Channel Blockers | 1 | 2018 | 694 | 0.030 |
Why?
|
Time | 1 | 2017 | 545 | 0.030 |
Why?
|
Algorithms | 1 | 2016 | 13982 | 0.030 |
Why?
|
Diarrhea | 1 | 2022 | 1319 | 0.030 |
Why?
|
Androgen Antagonists | 1 | 2023 | 1442 | 0.030 |
Why?
|
Embryo Transfer | 1 | 2018 | 522 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1722 | 0.030 |
Why?
|
Proline | 1 | 2016 | 457 | 0.030 |
Why?
|
Syndrome | 1 | 2020 | 3280 | 0.030 |
Why?
|
Fatigue | 1 | 2020 | 1544 | 0.030 |
Why?
|
Alanine | 1 | 2016 | 606 | 0.030 |
Why?
|
Glutamine | 1 | 2016 | 576 | 0.030 |
Why?
|
Infertility, Female | 1 | 2018 | 759 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1523 | 0.020 |
Why?
|
Medical Records | 1 | 2017 | 1407 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20509 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2016 | 788 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 667 | 0.020 |
Why?
|
Temperature | 1 | 2018 | 2221 | 0.020 |
Why?
|
Animals | 2 | 2021 | 167960 | 0.020 |
Why?
|
Quality of Life | 2 | 2023 | 13308 | 0.020 |
Why?
|
Decision Making | 1 | 2024 | 3925 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 74333 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2018 | 2061 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15840 | 0.020 |
Why?
|
Adolescent | 4 | 2019 | 87809 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8556 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15686 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2013 | 1548 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3765 | 0.020 |
Why?
|
Skin | 1 | 2018 | 4466 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 11713 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 25941 | 0.010 |
Why?
|
Prospective Studies | 2 | 2019 | 54306 | 0.010 |
Why?
|
Blood Glucose | 1 | 2016 | 6379 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10755 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20080 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9288 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2016 | 22052 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 8055 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2024 | 80345 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29661 | 0.010 |
Why?
|